Parnax Lab (BOM:506128) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Parnax Lab FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Parnax Lab's Free Cash Flow for the three months ended in Dec. 2023 was ₹0 Mil. Parnax Lab's Revenue for the three months ended in Dec. 2023 was ₹510 Mil. Therefore, Parnax Lab's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Parnax Lab's current FCF Yield % is 7.53%.

The historical rank and industry rank for Parnax Lab's FCF Margin % or its related term are showing as below:

BOM:506128' s FCF Margin % Range Over the Past 10 Years
Min: -8.44 Med: -3.06 Max: 7.25
Current: 5.26

During the past 13 years, the highest FCF Margin % of Parnax Lab was 7.25%. The lowest was -8.44%. And the median was -3.06%.

BOM:506128's FCF Margin % is ranked better than
64.88% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.06 vs BOM:506128: 5.26

Parnax Lab FCF Margin % Historical Data

The historical data trend for Parnax Lab's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnax Lab FCF Margin % Chart

Parnax Lab Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

-2.39

-4.65

-0.26

-5.69

5.75

Parnax Lab Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Parnax Lab's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Parnax Lab's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnax Lab's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnax Lab's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Parnax Lab's FCF Margin % falls into.

Parnax Lab FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Parnax Lab's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	96.298	/	1676.069
	=	5.75 %

Parnax Lab's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	509.886
	=	0.00 %

Parnax Lab FCF Margin % Related Terms

Thank you for viewing the detailed overview of Parnax Lab's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnax Lab (BOM:506128) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnax Lab Ltd (BOM:506128) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022

Website

https://www.naxparlab.com

Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.

Parnax Lab (BOM:506128) Headlines

No Headlines